87 results
424B4
BIOL
Biolase Inc
23 Apr 24
Prospectus supplement with pricing info
4:21pm
that is disproportionate to our operating performance.
The COVID-19 pandemic has adversely affected, and may continue to adversely affect, our business … include, but are not limited to:
substantial doubt about our ability to continue as a going concern;
the effects of the COVID-19 pandemic and the actions
POS AM
BIOL
Biolase Inc
19 Apr 24
Prospectus update (post-effective amendment)
5:07pm
and may fluctuate in a way that is disproportionate to our operating performance.
The COVID-19 pandemic has adversely affected, and may continue … of the COVID-19 pandemic and the actions taken to contain it;
losses that we have experienced for each of the past three years;
global economic uncertainty
POS AM
BIOL
Biolase Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:55pm
that is disproportionate to our operating performance.
The COVID-19 pandemic has adversely affected, and may continue to adversely affect, our business, results … of the COVID-19 pandemic and the actions taken to contain it;
losses that we have experienced for each of the past three years;
global economic
424B1
4t1qyxjr
14 Feb 24
Prospectus with pricing info
9:21pm
424B5
5iooafgqm hw9zt
8 Dec 23
Prospectus supplement for primary offering
9:23am
424B1
9d0lvdaxm
15 Sep 23
Prospectus with pricing info
5:27pm
424B1
dt6ds71g
15 Sep 23
Prospectus with pricing info
5:27pm